Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
30 August 2017 09:07
A new drug may carry a boost for heart attack and cancer patients
A study has discovered that a new drug could help cut cancer deaths, as well as potentially reduce the risk of heart attacks.
More than 10,000 patients, all of whom had previously had a heart attack but had not been diagnosed with cancer, took part in a trial using the anti-inflammatory Canakinumab.
They were treated once every three months and monitored for four years.
Milestone in a long journey
It was found that there was a 15% reduction in the risk of heart attacks and strokes, while cancer deaths were cut in half.
Commenting on the study, which was presented at the European Society of Cardiology meeting in Barcelona, Dr Paul Ridker of Brigham and Women's Hospital in Boston said it "represents a milestone in a long journey".
"For the first time, we've been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk," he said.
"This has far-reaching implications. It tells us that by leveraging an entirely new way to treat patients - targeting inflammation - we may be able to significantly improve outcomes for certain very high-risk populations."
He added that further research is needed into the drug's effects on cancer.
A platform for the future
Gary Gibbons, director of the National Heart, Lung and Blood Institute, said the results provide a platform on which to carry out further trials and research.
He added that while the trial offers "compelling evidence" that targeting inflammation efficacy is preventing recurrent cardiovascular events, the Institute is also looking forward to findings from additional trials, including the NHLBI-funded Cardiovascular Inflammation Reduction Trial, to help further refine the best therapeutic strategies for preventing heart disease.
People who have undergone cancer treatment in the past can arrange specialist medical travel insurance when taking holidays.
23 September 2017
Thomas Cook has launched a new service that will enable holidaymakers to select which hotel room they want, before even boarding a flight.
[more...]
22 September 2017
A new computer code that can be applied to GP surgery data could be the answer to identifying those most at risk of developing bowel cancer.
21 September 2017
The World Health Organisation (WHO) has issued a warning over a growing resistance to antibiotics.
20 September 2017
Thousands of Ryanair flights have been cancelled over the next six weeks, as the airline says it "messed up" allocation of its pilots' annual leave.
19 September 2017
Manchester's Girlguides are being urged to help the elderly with a new badge incentivising youngsters to tackle senior loneliness.
16 September 2017
Holidaymakers are being evacuated as winds up to 200km per hour hit Central Vietnam, with Typhoon Doksuri damaging houses, roads and infrastructure.
15 September 2017
People in parts of East Anglia are eight times more likely to survive liver disease than Blackpool residents, according to new data by Public Health England (PHE).
14 September 2017
A non-invasive alternative to gastric bypass surgery that helps people with Type 2 diabetes lose weight is being recommended for widespread use by NHS experts.
13 September 2017
Almost half of UK adults travelling to areas at risk of malaria are not covering themselves by taking medication, despite recommendations made by the NHS and world health organisations.
12 September 2017
A new health warning has been issued by scientists in Sweden, suggesting e-cigarettes with nicotine could lead to an increased risk of heart attacks and strokes.
09 September 2017
Researchers have developed a futuristic pen-like device that can tell whether someone has cancer much faster than current technology.
08 September 2017
A staffing crisis in the NHS is seeing cancer patients turned away from their GP surgery and instead visiting A&E, a report has claimed.